BUFFALO, N.Y. – A University at Buffalo researcher who studies adolescent HIV prevention in African and diaspora communities was invited to contribute a commentary in the April issue of The Lancet ...

Nigeria has received Lenacapavir, a long-acting HIV prevention injection taken twice a year. Health officials say the breakthrough could transform HIV prevention and reduce new infections across the ...

Nigeria has officially received Lenacapavir, a long-acting HIV prevention injection, marking a major milestone in the country’s fight against the epidemic. Approved by the Coordinating Minister of ...

While the rate of HIV in Kampala, Uganda, is more than double the national average, a recent survey of displaced youths in the city found that only about 20% consistently used condoms and just half of ...

Nonprofits received up to $400,000 each to expand prevention models led by community health workers. The two-year grants are part of a larger initiative that includes more than 30 organizations across ...

Please provide your email address to receive an email when new articles are posted on . Although HIV infection remains a global public health challenge, ART has transformed it from a fatal illness to ...

HARARE, Zimbabwe (AP) — Young women, mothers holding babies and some men lined up in a dusty field on the outskirts of Zimbabwe's capital, Harare. They came for injections of a new HIV prevention drug ...

Lenacapavir targets more than 46,000 high-risk individuals Rollout funded by U.S. and Global Fund Drug rollout to occur in phases across 24 sites nationwide HARARE, Feb 19 (Reuters) - Zimbabwe's ...

Lenacapavir is an approved HIV treatment given as a twice-yearly injection. In 2025, Nigeria joined global leaders in announcing a historic price reduction for a revolutionary HIV prevention drug.

A bill moving through the Georgia General Assembly could change how people in the state start HIV prevention medication. Senate Bill 195 would allow trained pharmacists to prescribe PrEP, a daily ...

Kenya will roll out a groundbreaking new HIV-prevention drug in March across 15 priority regions, the health ministry said on Wednesday. Lenacapavir, taken twice a year, has been shown to reduce the ...